il 12 febbraio Luke Whitesell del Whitehead Institute Cambridge scrive sul Pediatric Blood Cancer in memoria di Angelo Rosolen
After a much too brief life spent in service to children with cancer, Angelo Rosolen died from disseminated cancer of the biliary tract on December 19, 2013. Not surprisingly, he fought his brutal illness with the same kind of humility, dignity, and determination that marked his entire life. With his passing, the pediatric oncology community in Italy and all over the world has lost a wonderfully caring, committed, and talented physician- scientist.
Angelo was born in Treviso province of the Veneto region of Italy in 1959. Although his work took him all over the United States and Europe, he always thought of this beautiful area as his home. He pursued his medical and pediatric training at the University of Padova, an institution, which he served in a host of ways throughout his life. At the time of his death, he was Director of Pediatrics at Santa Maria della Misercordia clinic in Udine.
While Angelo’s clinical home was always the University of Padova, his scientific roots were at the U.S. National Cancer Institute where he did extensive post-doctoral work in molecular oncology. The widely recognized expertise that he developed in this field was central to his role as Chief of the Laboratory of Pediatric Solid Tumor Biology and Coordinator of the Molecular Oncology Diagnostics and Therapeutics Unit at the University of Padova. Nationally, this unit became the reference laboratory for the diagnosis and molecular characterization of Non-Hodgkin’s Lymphoma (NHL) and Soft Tissue Sarcoma (STS) for the entire Italian Association of Pediatric Hematology and Oncology (AIEOP). Internationally, he was coordinator of the International BFM Study Group’s NHL Committee and one of the founders of the European Intergroup for Childhood NHL (EICNHL). He gave further service to the community as coordinator of the Biology Committee for the European Soft Tissue Sarcoma Group (EpSSG).
Angelo’s life was a gift to all of us involved in pediatric oncology, patients, and practitioners alike. If it can serve now as an inspiration to redouble our efforts on behalf of children with cancer, nothing would make him happier.
Articolo pubblicato: venerdì, 14 marzo 2014